SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-122223
Filing Date
2024-04-29
Accepted
2024-04-29 16:06:17
Documents
18
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d810061ddef14a.htm   iXBRL DEF 14A 767722
6 GRAPHIC g810061g19j25.jpg GRAPHIC 103097
7 GRAPHIC g810061g34b61.jpg GRAPHIC 116003
8 GRAPHIC g810061g78q06.jpg GRAPHIC 108381
9 GRAPHIC g810061sp1.jpg GRAPHIC 3856
  Complete submission text file 0001193125-24-122223.txt   2192982

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA orgo-20231231.xsd EX-101.SCH 4747
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20231231_def.xml EX-101.DEF 4388
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20231231_lab.xml EX-101.LAB 6045
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20231231_pre.xml EX-101.PRE 3755
21 EXTRACTED XBRL INSTANCE DOCUMENT d810061ddef14a_htm.xml XML 99265
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37906 | Film No.: 24890632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)